NewAmsterdam Pharma Company NV Ordinary Shares

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$29,111
$2,127
$1,298
$1,594
Gross Profit
29,111
2,109
1,298
1,594
EBITDA
-16,620
-49,061
-54,574
-44,290
EBIT
-16,648
-49,078
-54,587
-44,295
Net Income
-16,647
-36,413
-86,893
-42,538
Net Change In Cash
29,111
2,127
1,298
1,594
Free Cash Flow
-12,577
-50,492
-51,165
-32,497
Cash
422,729
401,333
414,927
309,366
Basic Shares
94,754
94,711
82,160
82,477

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$12,762
$95,905
$0
$0
Gross Profit
12,762
95,905
-14
EBITDA
-165,687
-3,313
-30,726
-5,428
EBIT
-165,736
-3,321
-30,730
-5,429
Net Income
-176,937
-21,137
-36,712
-5,749
Net Change In Cash
12,762
95,905
0
0
Free Cash Flow
-141,242
7,959
-25,184
-5,983
Cash
340,450
438,522
53,092
7,861
Basic Shares
82,161
18,966
17,751
17,751

Earnings Calls

Quarter EPS
2024-09-30
-$0.18
2024-06-30
-$0.41
2024-03-31
-$1.06
2023-12-31
-$0.54